Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: improved technology for radiotherapy of cancer and other diseases

Aug. 10, 1999

Korean researchers synthesize anticancer platinum complexes

Aug. 10, 1999

NCI scientists initiate testing of thalidomide in colorectal cancer patients

Aug. 10, 1999

SCRAS team evaluates topoisomerase inhibitors for cancer indications

Aug. 10, 1999

Phase Ia results reported for Cell Pathways' novel SAAND

Aug. 10, 1999

Takeda scientists synthesize and evaluate GnRH antagonists

Aug. 9, 1999

Novel cell adhesion inhibitors in the pipeline at Roche

Aug. 9, 1999

Introgen Therapeutics obtains worldwide rights to mda7 gene from Corixa

Aug. 9, 1999

Fournier returns European rights for tgDCC-E1A to Targeted Genetics

Aug. 9, 1999

ADIR discloses alkaloid derivatives with improved potency and solubility

Aug. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...